Prelude Therapeutics Inc (PRLD)
3.90
+0.05
(+1.30%)
USD |
NASDAQ |
Apr 23, 16:00
3.90
0.00 (0.00%)
After-Hours: 20:00
Prelude Therapeutics Total Assets (Quarterly): 277.66M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 277.66M |
| September 30, 2023 | 258.51M |
| June 30, 2023 | 280.61M |
| March 31, 2023 | 198.32M |
| December 31, 2022 | 220.50M |
| September 30, 2022 | 242.33M |
| June 30, 2022 | 259.06M |
| March 31, 2022 | 280.67M |
| Date | Value |
|---|---|
| December 31, 2021 | 305.10M |
| September 30, 2021 | 331.22M |
| June 30, 2021 | 349.58M |
| March 31, 2021 | 369.83M |
| December 31, 2020 | 223.59M |
| September 30, 2020 | 239.68M |
| June 30, 2020 | 32.75M |
| December 31, 2019 | 21.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
21.87M
Minimum
Dec 2019
369.83M
Maximum
Mar 2021
243.20M
Average
258.78M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 40.58M |
| Shareholders Equity (Quarterly) | 237.09M |